RESEARCH FUNDING OPPORTUNITIES

IRSF believes that research into a variety of Rett and Rett-related topics is necessary to create treatments and eventual cures for every individual living with Rett syndrome. We proudly invest in such research at every stage: from basic science that can change the way we think about MeCP2 to clinical research that directly impacts potential treatments. We also help connect Rett researchers with external funding opportunities.

View Active & Previously Funded Research

IRSF FUNDING

From the generous support of our donors, we provide funding through the two grant mechanisms listed below. The grant cycle is currently closed.

  • Innovation Award
    • Letter of intent due: Closed
    • *DEADLINE EXTENDED* Full application due: Closed
  • Independence Award
    • Letter of intent due: Closed
    • *DEADLINE EXTENDED* Full application due: Closed

EXTERNAL FUNDING

IRSF advocates for external funding for Rett syndrome and supports Rett researchers in the pursuit of the below award mechanisms.

DOD Peer-Reviewed Medical Research Program (PRMRP) Awards
Rett syndrome officially became a topic eligible for FY22 funding through these awards on 3/11/2022. As we become aware of additional opportunities, we will list them here.

  • Discovery Awards (DAs)
    • Letter of intent due: Closed
    • Full application due: Closed
  • Investigator-Initiated Research Awards (IIRA)
    • Letter of intent due: Closed
    • Full application due: Closed
  • Technology/Therapeutic Development Awards (TTDAs)
    • Letter of intent due: Closed
    • Full application due: Closed
  • Focused Program Awards (FPAs)
    • Letter of intent due: Closed
    • Full application due: Closed
  • Clinical Trial Awards (CTAs)
    • Letter of intent due: Closed
    • Full application due: Closed

DOD Application Support